Lysophospholipid Growth Factors in the Initiation, Progression, Metastases, and Management of Ovarian Cancer
暂无分享,去创建一个
G. Mills | M. Mao | R. Lapushin | X. Fang | J. Wiener | A. Eder | V. Estrella | G B Mills | R. Jaffe | Jim Erickson | R B Jaffe | T Sasagawa | J R Wiener | X Fang | D Gaudette | T Furui | M Mao | V Estrella | A Eder | T Pustilnik | R Lapushin | S Yu | J R Erickson | T. Sasagawa | D. Gaudette | T. Pustilnik | Tatsuro Furui | Shiangxing Yu | Shuhong Yu | Xianjun Fang | Shiyi Yu
[1] Wouter,et al. Protein Tyrosine Phosphorylation Induced by Lysophosphatidic Acid in Rat-1 Fibroblasts , 2001 .
[2] G. Mills,et al. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] K. Liliom,et al. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes. , 1998, Molecular pharmacology.
[4] J. Fauvel,et al. Regulation of secretory type-II phospholipase A2 and of lysophosphatidic acid synthesis. , 1998, Advances in enzyme regulation.
[5] E. Goetzl,et al. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization. , 1998, Molecular pharmacology.
[6] H. Ueda,et al. Activation of Gi1 by lysophosphatidic acid receptor without ligand in the baculovirus expression system. , 1999, Biochemical and biophysical research communications.
[7] S. Barnhill,et al. CA 125: The past and the Future , 1998, The International journal of biological markers.
[8] K. Fukuzawa,et al. Substrate specificity of lysophospholipase D which produces bioactive lysophosphatidic acids in rat plasma. , 1999, Biochimica et biophysica acta.
[9] K. Jalink,et al. Lysophosphatidic acid: a novel phospholipid with hormone- and growth factor-like activities. , 1992, Cold Spring Harbor symposia on quantitative biology.
[10] Joe W. Gray,et al. PIK3CA is implicated as an oncogene in ovarian cancer , 1999, Nature Genetics.
[11] E Ruoslahti,et al. Integrins and anoikis. , 1997, Current opinion in cell biology.
[12] J. Chun,et al. A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] R. Lefkowitz,et al. Pleiotropic Coupling of G Protein-coupled Receptors to the Mitogen-activated Protein Kinase Cascade , 1999, The Journal of Biological Chemistry.
[14] S. Spiegel,et al. Dual Actions of Sphingosine-1-Phosphate: Extracellular through the Gi-coupled Receptor Edg-1 and Intracellular to Regulate Proliferation and Survival , 1998, The Journal of cell biology.
[15] G. Mills,et al. Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine(lysoPC) in ovarian cancer patients , 1997, International journal of cancer.
[16] G. Mills,et al. Lysophosphatidylcholine Stimulates Activator Protein 1 and the c-Jun N-terminal Kinase Activity* , 1997, The Journal of Biological Chemistry.
[17] M. Okita,et al. The significance of plasma lysophospholipids in patients with renal failure on hemodialysis. , 1998, Journal of nutritional science and vitaminology.
[18] S. Rodenhuis,et al. Malignant effusions contain lysophosphatidic acid (LPA)-like activity. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] J. Weiner,et al. Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate. , 1999, Gene.
[20] M. Okita,et al. Abnormal serum lysophospholipids in multiple myeloma patients , 1999, Lipids.
[21] Yan Xu,et al. Effect of lysophospholipids on signaling in the human Jurkat T cell line , 1995, Journal of cellular physiology.
[22] T. Sasaki,et al. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. , 1994, The Journal of biological chemistry.
[23] C. Marshall,et al. Lysophosphatidic acid stimulates mitogen-activated protein kinase activation via a G-protein-coupled pathway requiring p21ras and p74raf-1. , 1993, The Journal of biological chemistry.
[24] J. R. Erickson,et al. Edg-2/Vzg-1 Couples to the Yeast Pheromone Response Pathway Selectively in Response to Lysophosphatidic Acid* , 1998, The Journal of Biological Chemistry.
[25] K. Jalink,et al. Lysophosphatidic acid: a bioactive phospholipid with growth factor-like properties. , 1992, Reviews of physiology, biochemistry and pharmacology.
[26] E. Ruoslahti,et al. Control of adhesion-dependent cell survival by focal adhesion kinase , 1996, The Journal of cell biology.
[27] G. Mills,et al. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells. , 1990, The Journal of clinical investigation.
[28] P C Sternweis,et al. p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. , 1998, Science.
[29] A. Rustgi,et al. The c-myc oncoprotein forms a specific complex with the product of the retinoblastoma gene. , 1991, Cold Spring Harbor symposia on quantitative biology.
[30] K. Jacobson,et al. Adenosine A1 and A2 receptors: Structure–function relationships , 1992, Medicinal research reviews.
[31] J. Johnston,et al. Chemokines and serpentines: the molecular biology of chemokine receptors , 1993, Journal of leukocyte biology.
[32] M. Cybulsky,et al. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. , 1992, The Journal of clinical investigation.
[33] K. Jalink,et al. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin. , 1992, The Biochemical journal.
[34] M. Lipp,et al. EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. , 1998, Genomics.
[35] G. Mills,et al. Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] C. Fraser,et al. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. , 1992, The Biochemical journal.
[37] J. Gerrard,et al. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. , 1989, Biochimica et biophysica acta.
[38] K. Liliom,et al. Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[39] G. Schultz,et al. The G-protein G13 but Not G12 Mediates Signaling from Lysophosphatidic Acid Receptor via Epidermal Growth Factor Receptor to Rho* , 1998, The Journal of Biological Chemistry.
[40] R. Treisman,et al. The Rho family GTPases RhoA, Racl , and CDC42Hsregulate transcriptional activation by SRF , 1995, Cell.
[41] S. Frisch,et al. Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.
[42] J. Bockaert,et al. The metabotropic glutamate receptors: their second intracellular loop plays a critical role in the G-protein coupling specificity. , 1995, Biochemical Society transactions.
[43] Y. Xu,et al. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells. , 1998, Gynecologic oncology.
[44] C. H. Liu,et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. , 1998, Science.
[45] S. Kosugi,et al. The third exoplasmic loop of the thyrotropin receptor is partially involved in signal transduction , 1994, FEBS letters.
[46] P C Sternweis,et al. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. , 1998, Science.
[47] T. Miyata,et al. Changes of gene expression by lysophosphatidylcholine in vascular endothelial cells: 12 up-regulated distinct genes including 5 cell growth-related, 3 thrombosis-related, and 4 others. , 1998, Journal of biochemistry.
[48] Duane D. Miller,et al. Identification of a Novel Growth Factor-like Lipid, 1-O-cis-Alk-1′-enyl-2-lyso-sn-glycero-3-phosphate (Alkenyl-GP) That Is Present in Commercial Sphingolipid Preparations* , 1998, The Journal of Biological Chemistry.
[49] J. Weiner,et al. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex , 1996, The Journal of cell biology.
[50] W. Vetter,et al. Lysolecithin actions on vascular smooth muscle cells. , 1992, Biochemical and biophysical research communications.
[51] R. Miledi,et al. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. , 1992, The Journal of biological chemistry.
[52] G. Milligan,et al. Stimulation of high-affinity GTPase activity and cholera toxin-catalysed [32P]ADP-ribosylation of Gi by lysophosphatidic acid (LPA) in wild-type and alpha 2C10 adrenoceptor-transfected Rat 1 fibroblasts. , 1994, The Biochemical journal.
[53] E. Goetzl,et al. Characterization of a Novel Subtype of Human G Protein-coupled Receptor for Lysophosphatidic Acid* , 1998, The Journal of Biological Chemistry.
[54] E. Goetzl,et al. Signaling mechanisms and molecular characteristics of G protein‐coupled receptors for lysophosphatidic acid and sphingosine 1‐phosphate , 1998, Journal of cellular biochemistry. Supplement.
[55] D. Diviani,et al. Truncation of the receptor carboxyl terminus impairs agonist-dependent phosphorylation and desensitization of the alpha 1B-adrenergic receptor. , 1994, The Journal of biological chemistry.
[56] E. Goetzl,et al. Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. , 1998, Journal of cellular biochemistry.
[57] G. Mills,et al. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[58] K. Murakami‐Murofushi,et al. Inhibition of cell proliferation by a unique lysophosphatidic acid, PHYLPA, isolated from Physarum polycephalum: signaling events of antiproliferative action by PHYLPA. , 1993, Cell structure and function.
[59] K. Liliom,et al. N-palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors. , 1996, Molecular Pharmacology.
[60] T. Seufferlein,et al. Lysophosphatidic acid stimulates tyrosine phosphorylation of focal adhesion kinase, paxillin, and p130. Signaling pathways and cross-talk with platelet-derived growth factor. , 1994, The Journal of biological chemistry.
[61] M Markman,et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. , 1998, JAMA.
[62] M. Durieux,et al. Synergistic inhibition of lysophosphatidic acid signaling by charged and uncharged local anesthetics. , 1999, Anesthesia and analgesia.
[63] I. Fahrenfort,et al. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. , 1993, The Biochemical journal.
[64] Kees Jalink,et al. Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins , 1989, Cell.
[65] K. Reiss,et al. Insulin‐like growth factor‐I‐mediated survival from Anoikis: Role of cell aggregation and focal adhesion kinase , 1998, Journal of cellular physiology.
[66] P. Hordijk,et al. Protein tyrosine phosphorylation induced by lysophosphatidic acid in Rat-1 fibroblasts. Evidence that phosphorylation of map kinase is mediated by the Gi-p21ras pathway. , 1994, The Journal of biological chemistry.
[67] M. Durieux,et al. Intercellular Signaling By Lysophosphatidate Recent Developments , 1998 .
[68] J. Stankova,et al. Mutation of an aspartate at position 63 in the human platelet-activating factor receptor augments binding affinity but abolishes G-protein-coupling and inositol phosphate production. , 1996, Biochemical and biophysical research communications.
[69] E. Goetzl,et al. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1‐phosphate , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[70] G. Mills,et al. Lysophospholipids activate ovarian and breast cancer cells. , 1995, The Biochemical journal.
[71] G. Mills,et al. A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action. , 1988, Cancer research.
[72] S. Cook,et al. C3 Toxin Activates the Stress Signaling Pathways, JNK and p38, but Antagonizes the Activation of AP-1 in Rat-1 Cells* , 1999, The Journal of Biological Chemistry.
[73] A. Gilman,et al. p115 RhoGEF, a GTPase activating protein for Gα12 and Gα13 , 1998 .
[74] Ingrid,et al. Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1. , 1998, The Biochemical journal.
[75] G. Gundersen,et al. Rho Guanosine Triphosphatase Mediates the Selective Stabilization of Microtubules Induced by Lysophosphatidic Acid , 1998, The Journal of cell biology.
[76] T. Hla,et al. Lysophosphatidic Acid Stimulates the G-protein-coupled Receptor EDG-1 as a Low Affinity Agonist* , 1998, The Journal of Biological Chemistry.